PME — Pro Medicus Cashflow Statement
0.000.00%
Last trade - 00:00- AU$18.36bn
- AU$18.11bn
- AU$270.75m
Annual cashflow statement for Pro Medicus, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash from Operating Activities | 61.6 | 62.5 | 82 | 111 | 127 |
| Capital Expenditures | -9.02 | -6.45 | -6.69 | -7.38 | -8.69 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | -7.88 | -1.11 | -66.6 | 0.8 | -3.55 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -16.9 | -7.56 | -73.3 | -6.58 | -12.2 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -23.3 | -27.5 | -39.8 | -57.6 | -75.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.6 | 27.6 | -31.2 | 47.4 | 39 |